PRKDC and breast carcinoma: For example, studies have demonstrated that suppressing CDK5 can impede cell motility and tumor development in the mesenchymal breast cancer cell lines MDA-MB-231 and BT549 [39], while elevated expression of PRKDC promotes breast cancer cell proliferation by regulating p38 MAPK signaling [40].